KiNDD Lab: ABC-CT- Autism Biomarkers Consortium for Clinical Trials Confirmation Study

Study Summary

The purpose of this longitudinal study is to identify a set of sensitive and reliable measures that can be used in future clinical trials to objectively measure social impairment in individuals with autism spectrum disorders (ASD). Children will be assessed over a 6-month period using electroencephalography (EEG), eye tracking (ET) and other lab-based measures. The goal of this study is to accelerate the development of effective treatments for social impairment in ASD.

Who can participate?

We are actively enrolling children 6-11 years old who have a diagnosis of ASD, and children who are typically developing and do not have siblings with ASD.

What does the study involve?

Children will be assessed at three time points over a 6-month period using clinician and caregiver assessments, electroencephalogram (EEG), eye-tracking (ET), and lab-based measures. A one-time blood sample will also be collected from ASD subjects and their biological parents.

Call to participate

Want to participate in a research study? Please email autismresearch@chla.usc.edu to get in touch with one of our study coordinators.

Links

Autism Spectrum Disorder Fact Sheet | National Institute of Neurological Disorders and Stroke